InsidersTradesSigma
Follow the 케이바이오랩스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 케이바이오랩스 has logged 4 reports. Market capitalisation: €22.3bn. The latest transaction was disclosed on 2 July 2026 (Other). Among the most active insiders: 미래아이앤지. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
케이바이오랩스 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于生物制药解决方案的开发。